High burden of Carbapenem-resistant Enterobacteriaceae (CRE) fecal carriage at a teaching hospital: cost-effectiveness of screening in low-resource setting

Costs and possible benefits of a two-tier infection control management strategy consisting of active screening for multidrug-resistant organisms and tailored control measures

(2016) N.T. Mutters et al.   JOURNAL OF HOSPITAL INFECTION

Prevention and control of multi-drug-resistant Gram-negative bacteria: recommendations from a Joint Working Party

(2016) A.P.R. Wilson et al.   JOURNAL OF HOSPITAL INFECTION

The global epidemiology of carbapenemase-producing Enterobacteriaceae

(2016) David van Duin et al.   Virulence

Costs associated with implementation of a strict policy for controlling spread of highly resistant microorganisms in France

(2016) Gabriel Birgand et al.   BMJ Open

Notes from the Field: Carbapenem-resistant Enterobacteriaceae Producing OXA-48-like Carbapenemases — United States, 2010–2015

(2015) Meghan Lyman et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Routine active surveillance for carbapenemase-producing Enterobacteriaceae from rectal swabs: diagnostic implications of multiplex polymerase chain reaction

(2014) W. Lowman et al.   JOURNAL OF HOSPITAL INFECTION

A hospital-based matched case–control study to identify clinical outcome and risk factors associated with carbapenem-resistant Klebsiella pneumoniae infection

(2013) Luci Correa et al.   BMC INFECTIOUS DISEASES

The Global Spread of Healthcare-Associated Multidrug-Resistant Bacteria: A Perspective From Asia

(2013) James S. Molton et al.   CLINICAL INFECTIOUS DISEASES

Surveillance trends of carbapenem-resistant Enterobacteriaceae from Singapore, 2010–2013

(2013) Jeanette W.P. Teo et al.   Journal of Global Antimicrobial Resistance

Wide variation in adoption of screening and infection control interventions for multidrug-resistant organisms: A national study

(2012) Monika Pogorzelska et al.   AMERICAN JOURNAL OF INFECTION CONTROL

Costs of Healthcare- and Community-Associated Infections With Antimicrobial-Resistant Versus Antimicrobial-Susceptible Organisms

(2012) Matthew J. Neidell et al.   CLINICAL INFECTIOUS DISEASES

Asymptomatic rectal carriage of blaKPC producing carbapenem-resistant Enterobacteriaceae: who is prone to become clinically infected?

(2012) V. Schechner et al.   CLINICAL MICROBIOLOGY AND INFECTION

Antimicrobial-Resistant Pathogens Associated with Healthcare-Associated Infections Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010

(2012) Dawn M. Sievert et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Rectal Screening for Klebsiella pneumoniae Carbapenemases: Comparison of Real-Time PCR and Culture Using Two Selective Screening Agar Plates

(2012) K. Singh et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance

(2011) A.-P. Magiorakos et al.   CLINICAL MICROBIOLOGY AND INFECTION

Intervention to Reduce Transmission of Resistant Bacteria in Intensive Care

(2011) W. Charles Huskins et al.   NEW ENGLAND JOURNAL OF MEDICINE

Attributable Mortality Rate for Carbapenem-Resistant Klebsiella pneumoniae Bacteremia

(2009) Abraham Borer et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria

(2009) Patrice Nordmann et al.   LANCET INFECTIOUS DISEASES